Agf Investments Inc. Astrazeneca PLC Transaction History

Agf Investments Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 10, 2022	SELL	$55.72 - $67.12 $13,205 - $15,907	-237 Closed	0 $0
Q4 2021 Feb 01, 2022	SELL	$54.02 - $63.83 $54 - $63	-1 Reduced 0.42%	237 $14,000
Q3 2021 Nov 10, 2021	BUY	$55.56 - $60.79 $1,666 - $1,823	30 Added 14.42%	238 $14,000
Q2 2021 Aug 10, 2021	BUY	$48.42 - $60.18 $4,115 - $5,115	85 Added 69.11%	208 $12,000
Q1 2021 May 14, 2021	BUY	$47.16 - $54.44 $5,800 - $6,696	123 New	123 $6,000
Q2 2019 Jul 30, 2019	SELL	$37.28 - $41.68 $4.69 Million - $5.25 Million	-125,872 Closed	0 $0
Q1 2019 May 10, 2019	BUY	$35.49 - $43.02 $1.81 Million - $2.19 Million	50,872 Added 67.83%	125,872 $5.09 Million
Q4 2018 Feb 08, 2019	BUY	$36.86 - $41.49 $2.76 Million - $3.11 Million	75,000 New	75,000 $2.85 Million

1,361

475M

5.39M

3.75M

Ticker AZN
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 3,099,020,032
Market Cap $205B
Description
AstraZeneca PLC, a biopharmaceutical company, focuses on the discovery, development, manufacturing, and commercialization of prescription medicines. Its marketed products include Calquence, Enhertu, Faslodex, Imfinzi, Iressa, Koselugo, Lumoxiti, Lynparza, Orpathys, Tagrisso, and Zoladex for oncology; Brilinta/Brilique, Bydureon/Byetta, BCise, By...

Get notified when there are updates to the investment portfolio of Agf Investments Inc., based on Form 13F filings with the SEC.

Stay updated on Agf Investments Inc. with notifications on news.